Yes, both Danish and international start-ups will be taken into consideration. In DIANA regi though, only from the NATO member states.
Increased computing power will positively impact life sciences in various ways. It will, for example, make it easier to mathematically calculate conformations and quantum interactions in molecular systems, which paves the way for a significant acceleration in developing new drugs. Moreover, as Quantum computing can process a variety of data from several sources and make granular risk predictions, it can have a huge impact on the application of human healthcare data, diagnostics, and precision medicine, which could subsequently impact drug & treatment pricing. From a sustainability perspective, increased computing power is essential for optimizing energy systems. Optimized energy systems should be capable of channelizing green energy production to those places with the most significant energy demand. Optimizing processes and making them more energy-efficient can also decrease the overall energy usage of computing power. At the same time, computing power will help in the overall understanding of bio-based energy production.
There is already significant interest from long-term investors in this area, and BII aims to build a strong network of investors that can further strengthen the development of a robust innovation environment in quantum technologies. NATO recently announced a €1B NATO Innovation Fund, which could provide deep tech start-ups with investment opportunities. Read more here: NATO - News: NATO launches Innovation Fund, 30-Jun.-2022 Other investors in quantum technology have included big tech companies, major tech VC's, dedicated Deep Tech VCs, and several government funds across the world.
A Deep Tech accelerator program is different from other types of accelerator programs in a few key ways. It focuses on start-ups that are developing advanced technologies that require significant expertise and investment to develop. These programs often have a longer and more complex development process, require specialized mentors and experts, and are focused on creating disruptive innovations that have the potential to transform entire industries. In contrast, other types of accelerator programs may focus on a broader range of start-ups and have shorter-term goals.

BioInnovation Institute (BII) accelerates world-class life science start-up innovation to bring forward products and services that benefit people and society. As a non-profit institute, BII operates the company creation programs Bio Studio and the company acceleration programs Venture Lab and Venture House. In all programs, BII supports planetary and human health start-ups with knowledge, network, infrastructure and funding. We empower early-stage start-ups to succeed and believe in the transformative power of life science innovation. Read more on